Back to search

Belgium· BE-AMP-SAM271765-00

Venoruton Forte 500 mg

A troxerutin, kombinationen, inkl. oxerutine product containing rutoside, registered in Belgium by Impexeco. The same ATC class is registered in 4 of our 19 countries.

ATC C05CA54

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedVenoruton Forte 500 mgATCC05CA54REGISTER NO.BE-AMP-SAM271765-00PACKS LISTED2CHECKEDSeptember 26, 2026

Where it is registered

Troxerutin, kombinationen, inkl. oxerutine is registered in 4 of 19 countries.

Countries holding a registration under ATC C05CA54 (troxerutin, kombinationen, inkl. oxerutine), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 4 of them publish a price we can compare per daily dose

Troxerutin, kombinationen, inkl. oxerutine · ATC C05CA54

4 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Rutoside
Manufacturer
Impexeco
Country
Belgium (BE)
ATC code
C05CA54
ATC class
Troxerutin, Kombinationen, inkl. Oxerutine
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 2

  • be_apb
    2190916
  • be_apb
    2981082

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Troxerutin, kombinationen, inkl. oxerutine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All troxerutin, kombinationen, inkl. oxerutine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/91f0e01b-325f-4654-bb37-75ee0ed9ac89
GET /v1/drugs/91f0e01b-325f-4654-bb37-75ee0ed9ac89?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Venoruton Forte 500 mg",
  "name_fr": "Venoruton Forte 500 mg",
  "name_nl": "Venoruton Forte 500 mg",
  "amp_code": "SAM271765-00",
  "strengths": [
    "500.0000",
    "500.0000"
  ],
  "pack_count": 7,
  "substances": [
    "Rutoside",
    "O-(ß-Hydroxyethyl) Rutinosides"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Troxerutin, Combinations",
  "authorisation_numbers": [
    "1549PI0034F003",
    "1549PI0234F003"
  ]
}

See everything about troxerutin, kombinationen, inkl. oxerutine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.